MEDICOX Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 5,839.84 million compared to KRW 4,437.26 million a year ago. Net loss was KRW 14,762.38 million compared to KRW 5,503.1 million a year ago. Basic loss per share from continuing operations was KRW 708.5 compared to KRW 365 a year ago. Diluted loss per share from continuing operations was KRW 708.5. Basic loss per share was KRW 708.5 compared to KRW 365 a year ago.
For the nine months, sales was KRW 0.00048 million compared to negative sales of KRW 0.00027 million a year ago. Net loss was KRW 22,197.15 million compared to KRW 11,617.25 million a year ago. Basic loss per share from continuing operations was KRW 1,125.5 compared to KRW 995 a year ago. Diluted loss per share from continuing operations was KRW 1,125.5 compared to KRW 995 a year ago. Basic loss per share was KRW 1,125.5 compared to KRW 995 a year ago.